Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1992 2
1996 2
1997 1
1999 2
2000 2
2002 3
2003 2
2004 4
2005 3
2006 4
2007 5
2008 6
2009 7
2010 7
2011 9
2012 16
2013 11
2014 14
2015 11
2016 19
2017 20
2018 14
2019 16
2020 16
2021 14
2022 12
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Taylor PC, Bieber T, Alten R, Witte T, Galloway J, Deberdt W, Issa M, Haladyj E, De La Torre I, Grond S, Wollenberg A. Taylor PC, et al. Among authors: alten r. Adv Ther. 2023 Apr;40(4):1867-1883. doi: 10.1007/s12325-023-02445-w. Epub 2023 Feb 20. Adv Ther. 2023. PMID: 36802049 Free PMC article. Clinical Trial.
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.
Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, Lopez-Romero P, Fakhouri W, de la Torre I, Zaremba-Pechmann L, Holzkämper T, Fautrel B. Alten R, et al. Rheumatol Ther. 2023 Feb;10(1):73-93. doi: 10.1007/s40744-022-00500-6. Epub 2022 Oct 13. Rheumatol Ther. 2023. PMID: 36227530 Free PMC article.
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, Klearman M, Musselman D, Agarwal S, Green J, Kavanaugh A; ADACTA Study Investigators. Gabay C, et al. Among authors: alten r. Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18. Lancet. 2013. PMID: 23515142 Clinical Trial.
New concepts to reduce glucocorticoid toxicity.
Alten R, Mischkewitz M. Alten R, et al. Joint Bone Spine. 2019 Nov;86(6):715-723. doi: 10.1016/j.jbspin.2018.11.006. Epub 2018 Dec 5. Joint Bone Spine. 2019. PMID: 30528678 Review.
Macrophagic Myofasciitis.
Stenzel W, Heppner FL, Goebel HH, Alten RH. Stenzel W, et al. Among authors: alten rh. Dtsch Arztebl Int. 2009 Apr;106(14):248. doi: 10.3238/arztebl.2009.0248a. Epub 2009 Apr 3. Dtsch Arztebl Int. 2009. PMID: 19547641 Free PMC article. No abstract available.
[Update on kinase inhibitors].
Alten R. Alten R. Z Rheumatol. 2016 Aug;75(6):611-5. doi: 10.1007/s00393-016-0113-3. Z Rheumatol. 2016. PMID: 27365023 Review. German. No abstract available.
[Autoimmune reactions to immune checkpoint inhibitors].
Pönisch W, Alten R, Baerwald C. Pönisch W, et al. Among authors: alten r. Z Rheumatol. 2017 Oct;76(Suppl 2):57-62. doi: 10.1007/s00393-017-0368-3. Z Rheumatol. 2017. PMID: 29330759 Review. German.
[Genitourinary malignancies and rheumatoid arthritis].
Boegemann M, Alten R, Aringer M, Zastrow S. Boegemann M, et al. Among authors: alten r. Z Rheumatol. 2016 Feb;75(1):54-62. doi: 10.1007/s00393-015-0031-9. Z Rheumatol. 2016. PMID: 26786167 Review. German.
Clinical trial development for biosimilars.
Alten R, Cronstein BN. Alten R, et al. Semin Arthritis Rheum. 2015 Jun;44(6 Suppl):S2-8. doi: 10.1016/j.semarthrit.2015.04.002. Semin Arthritis Rheum. 2015. PMID: 26058550 Free article. Review.
Maximizing the success of biosimilar implementation.
Alten R, Weinbrecht-Mischkewitz M. Alten R, et al. Nat Rev Rheumatol. 2023 Dec;19(12):757-758. doi: 10.1038/s41584-023-01048-7. Nat Rev Rheumatol. 2023. PMID: 37903917 No abstract available.
212 results